Hysteroscopic treatment of submucosal fibroids in perimenopausal women: when, why, and how?

References

• Styer AK, Rueda BR. The epidemiology and genetics of uterine leiomyoma. Best Pract Res Clin Obstet Gynaecol 2016;34:3–12
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Ishi K, Serna VA, et al. Progesterone is essential for maintenance and growth of uterine leiomyoma. Endocrinology 2010;151:2433–42
   PubMed Web of Science ®Google Scholar
• Moravek MB, Bulun SE. Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution. Curr Opin Obstet Gynecol 2015;27:276–83
   PubMed Web of Science ®Google Scholar
• Bulun SE. Uterine fibroids. N Engl J Med 2013;369:1344–55
   PubMed Web of Science ®Google Scholar
• Islam MS, Ciavattini A, Petraglia F, et al. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics. Hum Reprod Update 2018;24:59–85
   PubMed Web of Science ®Google Scholar
• Baird DD, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003;188:100–7
   PubMed Web of Science ®Google Scholar
• Stewart EA, Cookson CL, Gandolfo RA, et al. Epidemiology of uterine fibroids: a systematic review. BJOG 2017;124:1501–12
   PubMed Web of Science ®Google Scholar
• Donnez J, Courtoy GE, Dolmans MM. Fibroid management in premenopausal women. Climacteric 2019;22:27–33
   PubMed Web of Science ®Google Scholar
• Munro MG, Critchley HO, Broder MS, et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011;113:3–13
   PubMed Web of Science ®Google Scholar
• Piecak K, Milart P. Hysteroscopic myomectomy. Prz Menopauzalny 2017;16:126–8
   PubMedGoogle Scholar
• Williams A. Uterine fibroids – what’s new? F1000Res 2017;6:2109
   PubMedGoogle Scholar
• Nappi C, Di Spiezio Sardo A. State-of-the-art Hysteroscopic Approaches to Pathologies of the Genital Tract. Tuttlingen, Germany: Endo-Press; 2014
   Google Scholar
• Adel M, Kandil M, Abo-Elnasr M, et al. Three-dimensional sonohysterography may replace hysteroscopy for women with perimenopausal bleeding. Climacteric 2014;17:55–9
   PubMed Web of Science ®Google Scholar
• Deshmukh SP, Gonsalves CF, Guglielmo FF, et al. Role of MR imaging of uterine leiomyomas before and after embolization. Radiographics 2012;32:E251–281
   PubMed Web of Science ®Google Scholar
• Puri K, Famuyide AO, Erwin PJ, et al. Submucosal fibroids and the relation to heavy menstrual bleeding and anemia. Am J Obstet Gynecol 2014;210:38 e31–37
   Web of Science ®Google Scholar
• Sriprasert I, Pakrashi T, Kimble T, et al. Heavy menstrual bleeding diagnosis and medical management. Contracept Reprod Med 2017;2:20
   PubMedGoogle Scholar
• Tanos V, Berry KE. Benign and malignant pathology of the uterus. Best Pract Res Clin Obstet Gynaecol 2018;46:12–30
   PubMed Web of Science ®Google Scholar
• Ciarmela P, Ciavattini A, Giannubilo SR, et al. Management of leiomyomas in perimenopausal women. Maturitas 2014;78:168–73
   PubMed Web of Science ®Google Scholar
• Valentine LN, Bradley LD. Hysteroscopy for abnormal uterine bleeding and fibroids. Clin Obstet Gynecol 2017;60:231–44
   PubMed Web of Science ®Google Scholar
• Hapangama DK, Bulmer JN. Pathophysiology of heavy menstrual bleeding. Womens Health (Lond Engl) 2016;12:3–13
   PubMedGoogle Scholar
• Cormio G, Loizzi V, Ceci O, et al. Unsuspected diagnosis of uterine leiomyosarcoma after laparoscopic myomectomy. J Obstet Gynaecol 2015;35:211–12
   PubMedGoogle Scholar
• Nappi L, Di Spiezio Sardo A, Indraccolo U, et al. Hysteroscopic resection of uterine leiomyosarcoma: a case report and literature review. J Minim Invasive Gynecol 2008;15:380–3
   PubMed Web of Science ®Google Scholar
• Perot G, Croce S, Ribeiro A, et al. MED12 alterations in both human benign and malignant uterine soft tissue tumors. PLoS One 2012;7:e40015
   PubMed Web of Science ®Google Scholar
• Rubisz P, Ciebiera M, Hirnle L, et al. The usefulness of immunohistochemistry in the differential diagnosis of lesions originating from the myometrium. Int J Mol Sci 2019;20:1136
   Web of Science ®Google Scholar
• Roberts ME, Aynardi JT, Chu CS. Uterine leiomyosarcoma: a review of the literature and update on management options. Gynecol Oncol 2018;151:562–72
   PubMed Web of Science ®Google Scholar
• Friedman JA, Wong JMK, Chaudhari A, et al. Hysteroscopic myomectomy: a comparison of techniques and review of current evidence in the management of abnormal uterine bleeding. Curr Opin Obstet Gynecol 2018;30:243–51
   PubMed Web of Science ®Google Scholar
• Yendru KS, Yelamanchi SD, Vaddiraju GB. Hysteroscopic resection of submucous fibroids in symptomatic women. J Obstet Gynecol India 2019;69:166–72
   PubMed Web of Science ®Google Scholar
• Cianci S, Gueli Alletti S, Rumolo V, et al. Total laparoscopic hysterectomy for enlarged uteri: factors associated with the rate of conversion to open surgery. J Obstet Gynaecol 2019;39:805–10
   PubMedGoogle Scholar
• La Rosa VL, Shah M, Kahramanoglu I, et al. Quality of life and fertility preservation counseling for women with gynecological cancer: an integrated psychological and clinical perspective. J Psychosom Obstet Gynaecol 2019 Aug 2. Epub ahead of print
   Web of Science ®Google Scholar
• Elahi SM, Odejinmi F. Overview of current surgical management of fibroids: ‘organ-preserving modalities’. J Obstet Gynaecol 2008;28:28–31
   PubMedGoogle Scholar
• Maki PM, Kornstein SG, Joffe H, et al. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause 2018;25:1069–85
   PubMed Web of Science ®Google Scholar
• Theunissen M, Peters ML, Schepers J, et al. Prevalence and predictors of depression and well-being after hysterectomy: an observational study. Eur J Obstet Gynecol Reprod Biol 2017;217:94–100
   PubMed Web of Science ®Google Scholar
• Fortin C, Hur C, Falcone T. Impact of laparoscopic hysterectomy on quality of life. J Minim Invasive Gynecol 2019;26:219–32
   PubMed Web of Science ®Google Scholar
• Lee HJ, Kim SJ, Park EC. Psychiatric outcomes after hysterectomy in women with uterine myoma: a population-based retrospective cohort study. Arch Womens Ment Health 2017;20:487–94
   PubMed Web of Science ®Google Scholar
• Verpalen IM, Anneveldt KJ, Nijholt IM, et al. Magnetic resonance-high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: a systematic review and meta-analysis. Eur J Radiol 2019;120:108700
   PubMed Web of Science ®Google Scholar
• Loffer FD. Hysteroscopic myomectomy in postmenopausal women. J Minim Invasive Gynecol 2005;12:323–5
   PubMed Web of Science ®Google Scholar
• Qu DC, Chen Y, Yang MM, et al. High-intensity focused ultrasound for treatment of type 2 submucous myomas more than 4 centimeters in diameter prior to hysteroscopic myomectomy. J Minim Invasive Gynecol 2019 Aug 14. Epub ahead of print
   PubMedGoogle Scholar
• Di Spiezio Sardo A, Mazzon I, Bramante S, et al. Hysteroscopic myomectomy: a comprehensive review of surgical techniques. Hum Reprod Update 2008;14:101–19
   PubMed Web of Science ®Google Scholar
• Vitale SG. The biopsy snake grasper sec. VITALE: a new tool for office hysteroscopy. J Minim Invasive Gynecol 2019 Dec 26. Epub ahead of print
   Google Scholar
• Vitale SG, Haimovich S, Riemma G, et al. Innovations in hysteroscopic surgery: expanding the meaning of “in-office”. Minim Invasive Ther Allied Technol 2020 Jan 23. Epub ahead of print
   Web of Science ®Google Scholar
• Ciebiera M, Łoziński T, Wojtyła C, et al. Complications in modern hysteroscopic myomectomy. Ginekol Pol 2018;89:398–404
   PubMed Web of Science ®Google Scholar
• Sobociński K, Doniec J, Biela M, et al. Usefulness of cryoprobe in office hysteroscopy for removal of polyps and myomas. Biomed Res Int 2018;2018:1–6
   Web of Science ®Google Scholar
• Cicinelli E, Mitsopoulos V, Fascilla FD, et al. The OPPIuM technique: office hysteroscopic technique for the preparation of partially intramural leiomyomas. Minerva Ginecol 2016;68:328–33
   PubMed Web of Science ®Google Scholar
• Capmas P, Levaillant JM, Fernandez H. Surgical techniques and outcome in the management of submucous fibroids. Curr Opin Obstet Gynecol 2013;25:332–8
   PubMed Web of Science ®Google Scholar
• Tinelli A, Favilli A, Lasmar RB, et al. The importance of pseudocapsule preservation during hysteroscopic myomectomy. Eur J Obstet Gynecol Reprod Biol 2019;243:179–84
   PubMed Web of Science ®Google Scholar
• Haimovich S, Mancebo G, Alameda F, et al. Feasibility of a new two-step procedure for office hysteroscopic resection of submucous myomas: results of a pilot study. Eur J Obstet Gynecol Reprod Biol 2013;168:191–4
   PubMed Web of Science ®Google Scholar
• Vitale SG, Bruni S, Chiofalo B, et al. Updates in office hysteroscopy: a practical decalogue to perform a correct procedure. Updates Surg 2020 Feb 1. Epub ahead of print
   Web of Science ®Google Scholar
• Vitale SG, Sapia F, Rapisarda AMC, et al. Hysteroscopic morcellation of submucous myomas: a systematic review. Biomed Res Int 2017;2017:6848250
   PubMed Web of Science ®Google Scholar
• Kamath MS, Kalampokas EE, Kalampokas TE. Use of GnRH analogues pre-operatively for hysteroscopic resection of submucous fibroids: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2014;177:11–18
   PubMed Web of Science ®Google Scholar
• Schlaff WD, Ackerman RT, Al-Hendy A, et al. Elagolix for heavy menstrual bleeding in women with uterine fibroids. N Engl J Med 2020;382:328–40
   PubMed Web of Science ®Google Scholar
• Barra F, Seca M, Della Corte L, et al. Relugolix for the treatment of uterine fibroids. Drugs Today 2019;55:503–12
   PubMed Web of Science ®Google Scholar
• Perez-Lopez FR. Ulipristal acetate in the management of symptomatic uterine fibroids: facts and pending issues. Climacteric 2015;18:177–81
   PubMed Web of Science ®Google Scholar
• Chabbert-Buffet N, Kolanska K, Darai E, et al. Selective progesterone receptor modulators: current applications and perspectives. Climacteric 2018;21:375–9
   PubMed Web of Science ®Google Scholar
• Vitale SG, Ferrero S, Caruso S, et al. Ulipristal acetate before hysteroscopic myomectomy: a systematic review. Obstet Gynecol Surv 2020;75:127–35
   PubMed Web of Science ®Google Scholar
• Donnez J, Tatarchuk TF, Bouchard P, et al. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med 2012;366:409–20
   PubMed Web of Science ®Google Scholar
• Meunier L, Meszaros M, Pageaux GP, et al. Acute liver failure requiring transplantation caused by ulipristal acetate. Clin Res Hepatol Gastroenterol 2020 Mar 4. Epub ahead of print
   Google Scholar
• Del Forno S, Degli Esposti E, Salucci P, et al. Liver function, tolerability and satisfaction during treatment with ulipristal acetate in women with fibroids: a single center experience. Gynecol Endocrinol 2019 Oct 24. Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Ciebiera M, Vitale SG, Ferrero S, et al. Vilaprisan, a new selective progesterone receptor modulator in uterine fibroid pharmacotherapy – will it really be a breakthrough? Curr Pharm Des 2020;26:300–9
   PubMed Web of Science ®Google Scholar